Samsara BioCapital’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $755K | Hold |
202,348
| – | – | 0.15% | 25 |
|
|
2025
Q1 | $558K | Hold |
202,348
| – | – | 0.1% | 30 |
|
|
2024
Q4 | $1.12M | Hold |
202,348
| – | – | 0.15% | 33 |
|
|
2024
Q3 | $1.69M | Hold |
202,348
| – | – | 0.32% | 30 |
|
|
2024
Q2 | $1.38M | Hold |
202,348
| – | – | 0.29% | 30 |
|
|
2024
Q1 | $1.33M | Hold |
202,348
| – | – | 0.21% | 32 |
|
|
2023
Q4 | $1.31M | Hold |
202,348
| – | – | 0.2% | 30 |
|
|
2023
Q3 | $1.02M | Hold |
202,348
| – | – | 0.31% | 32 |
|
|
2023
Q2 | $1.77M | Hold |
202,348
| – | – | 0.31% | 32 |
|
|
2023
Q1 | $2.4M | Hold |
202,348
| – | – | 0.5% | 31 |
|
|
2022
Q4 | $2.06M | Sell |
202,348
-86,720
| -30% | -$883K | 0.44% | 32 |
|
|
2022
Q3 | $1.7M | Hold |
289,068
| – | – | 0.4% | 37 |
|
|
2022
Q2 | $717K | Hold |
289,068
| – | – | 0.19% | 45 |
|
|
2022
Q1 | $859K | Hold |
289,068
| – | – | 0.22% | 47 |
|
|
2021
Q4 | $2.04M | Hold |
289,068
| – | – | 0.4% | 35 |
|
|
2021
Q3 | $3.01M | Hold |
289,068
| – | – | 0.47% | 32 |
|
|
2021
Q2 | $3.54M | Sell |
289,068
-208,487
| -42% | -$2.56M | 0.44% | 31 |
|
|
2021
Q1 | $10.9M | Buy |
+497,555
| New | +$10.9M | 2.02% | 13 |
|